ExPlas
Asset
Transfers plasma from young, exercise-trained donors to deliver potentially beneficial circulating factors.
- Stage
- Phase 2
- Modality
- Plasma or blood product
- Target
- Not known
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Alzheimer's disease
Phase 2, Active not recruiting, NCT05068830, clinicaltrials.gov, Oct 30, 2026
In the full profile
- Owner and partners1
- Trials1
- Competitors2
- Aging relevance1
Every asset’s record: target, stage, trials and the evidence behind it.